[Head and neck sarcomas. Our experience]

Acta Otorrinolaringol Esp. 2011 Nov-Dec;62(6):436-42. doi: 10.1016/j.otorri.2011.05.005. Epub 2011 Aug 5.
[Article in Spanish]

Abstract

Introduction: Head and neck sarcomas are a heterogeneous group of malignant tumours that vary greatly in clinical presentation, with different histopathological and biological characteristics.

Material and methods: This was a retrospective study of patients with sarcoma located in the head and neck treated in our centre over a period of 25 years.

Results: During the study period, a total of 25 patients were diagnosed with sarcomas in the head and neck, accounting for 0.5% of all malignancies at this level. The most common treatments included surgical resection of the tumour, often supplemented with radiotherapy and/or adjuvant chemotherapy. The final local control, including the salvage, was 52%, with an adjusted survival of 51% at 5 years and 32% at 12 years.

Conclusions: Surgical treatment of patients with head and neck sarcomas achieves acceptable results of local control and survival.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Chemotherapy, Adjuvant
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Female
  • Head and Neck Neoplasms / epidemiology*
  • Head and Neck Neoplasms / therapy
  • Humans
  • Infant
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / epidemiology
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Sarcoma / epidemiology*
  • Sarcoma / pathology
  • Sarcoma / therapy
  • Spain / epidemiology
  • Treatment Outcome
  • Young Adult